Aspen Pharmacare Holdings - Thrombosis Business - Ownership and Business Overview

Life ScienceCompany

Aspen Pharmacare Holdings - Thrombosis Business Ownership

Who owns Aspen Pharmacare Holdings - Thrombosis Business?

Aspen Pharmacare Holdings - Thrombosis Business is owned by Viatris. It was acquired on September 8, 2020.

Aspen Pharmacare Holdings - Thrombosis Business Business Overview

Where is Aspen Pharmacare Holdings - Thrombosis Business headquartered?

Aspen Pharmacare Holdings - Thrombosis Business is headquartered in United Kingdom.

What sector is Aspen Pharmacare Holdings - Thrombosis Business in?

Aspen Pharmacare Holdings - Thrombosis Business is a life science company.

Life Science M&A Summary in 2020

Out of 60 sectors in the Mergr database, life science ranked 7 in number of deals in 2020. The largest life science acquisition in 2020 was Alexion Pharmaceuticals - which was acquired by AstraZeneca for $39.0B.

Join Mergr to view all 290 acquisitions of life science companies in 2020, including 23 acquisitions by private equity firms, and 267 by strategics.

Aspen Pharmacare Holdings Ltd. - Thrombosis Business


United Kingdom,

Aspen Pharmacare's Thrombosis Business is a global offering comprised largely of a broad range of specialist injectable anticoagulants. Aspen's portfolio also includes Orgaran which is a heparin derivative (heparinoid) indicated for the treatment of HIT. HIT is an adverse reaction occurring in a limited number of patients undergoing heparin related therapy. It offers healthcare providers the advantage of a single supplier that addresses broad clinical needs and thus ensures the optimal care of patients at risk of thrombosis.


 Subscribe to unlock this and 208,055
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.6K Private Equity Firms
  • 201K M&A Transactions
  • 203K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.6K M&A Advisors
    (Investment Banks and Law Firms)
  • 81K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.

Related Lists for Aspen Pharmacare Holdings - Thrombosis Business

Life Science Companies , United Kingdom Companies